Skip to main content
. 2019 May 23;44:162–181. doi: 10.1016/j.ebiom.2019.05.040

Fig. 12.

Fig. 12

Quantification of IILS deployment in five manufacturers. (a) Histogram showing scores in each scale across 5 manufacturers, and (b) each scale was compared between the patient and normal control groups among all manufacturers. Total score, which was summed by each scale, was compared in the same way as in (c-d). Statistical significance is labeled * for <0·05.